Both in Lab Analytical Instruments
Harvard Bioscience vs Nautilus Biotechnolgy
Over the past year HBIO returned +72.3% and NAUT returned +105.3%; their daily moves had a correlation of 0.03.
HBIO +72.3% NAUT +105.3%Growth of $1, one year, split-adjusted
| Metric | HBIO | NAUT |
|---|---|---|
| Price | $8.90 | $2.73 |
| Market cap | $40.5M | $347.7M |
| Today | +1.14% | −13.06% |
| 1 month | +9.5% | +73.9% |
| 6 months | +39.9% | +1.1% |
| Year to date | +33.1% | +40.0% |
| 1 year | +99.3% | +93.6% |
| Revenue growth (YoY) | +11.1% | — |
| Gross margin | 55.6% | 89.7% |
| Net margin | −12.8% | −6682.1% |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | 820.1× |
| Net cash | -$30.2M | $86.6M |
| Dividend yield | — | — |
| Volatility (60d) | 36.4% | 152.3% |
| Short % of float | 1.5% | 10.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).